1. Product form vilprafen
2. Pharmacological action
4. Guide vilprafen
5. Application vilprafen during pregnancy
6. Side effects
Vilprafen - macrolide antibiotic that has antibacterial, bacteriostatic properties.
drug produced in the form of suspensions and tablets.1 tablet vilprafen Soljutab contains 1000 mg of the active ingredient - josamycin, in turn Vilprofen 1 tablet contains 500 mg of josamycin.white tablets have an oblong shape.
as auxiliary components are: microcrystalline cellulose, precipitated silica, magnesium stearate, polysorbate, sodium carboxymethylcellulose, polyethylene glycol, methylcellulose, titanium oxide, esters of methacrylic acid.
contains 300 mg of josamycin in the 10 ml suspension.The slurry produced in special dark glass bottles of 100 ml.
The drug is an antibiotic that belongs to the group makrolitov.The bacteriostatic effect of the drug due to inhibition of
According to the instructions, Vilprafen is highly effective against such intracellular microorganisms such as Mycoplasma pneumoniae, Ureaplasma urealyticum, Chlamydia trachomatis, Legionella pneumophila, Chlamydia pneumonuae, Mycoplasma hominis.High activity is observed also against gram-negative aerobic bacteria: Haemophilus influenzae, Neisseria meningitidis, Neisseria gonorrhoeae, Bordetella pertussis;Gram-positive aerobic bacteria: Streptococcus pyogenes, Staphylococcus aureus, Corynebacterium diphtheriae, Streptococcus pneumoniae;anaerobic bacteria: Peptostreptococcus, Peptococcus, Clostridium perfringens.
According to reviews of Vilprafene, the drug is effective against Treponema pallidum.
vilprafen The active ingredient, as well as Vilprofen Soljutab, josamycin acts that completely and at a high speed is absorbed from the gastrointestinal tract.
Indications from Vilprafen and Vilprafen Soljutab identical tablets.According to the instructions, Vilprafen recommended for the treatment of acute and chronic infectious and inflammatory diseases caused by microorganisms sensitive to the drug:
vilprafen According to instructions, the recommended dose is 1-2 grams per day for adults and children over 14 years.The daily dose and vilprafen vilprafen Soljutab divided into 2-3 doses.Vilprafen should be taken between meals, not chewed tablets.
recommended to take 500 mg 2 times a day 12-14 days in the case of treatment of urogenital chlamydiosis;rosacea - 500 mg 2 times a day for 10-15 days;pyoderma - 500 mg 2 times a day for 10 days.
Chronic periodontitis is treated 12-14 days, while the drug is used at 500 mg 2 times a day.
In each case, the duration of the drug is determined by the doctor.
Babies from birth to 14 years of drug is given in the form of a suspension.The recommended daily dose is 30-50 mg / kg body weight.
drug is not indicated for pregnant women, if there are serious violations of the liver, the sensitivity to the ingredients.
Vilprafen during pregnancy is assigned on special indications.Mostly Vilprafen during pregnancy is indicated for the treatment of chlamydial infections.In such cases it is necessary to take the drug at 500 mg three times a day for 10-14 days.
According to reviews of Vilprafene, use of the drug may be associated with the occurrence of allergic reactions such as urticaria.There may also be loss of appetite, goiter, nausea, diarrhea, heartburn.In some cases, jaundice appears.
Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.The information is provided for informational purposes only and is not a guide to self-medication.Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.
Contents: 1. Composition and pharmacological properties 2. Indications Symbicort 3. Instruction Symbicort 4. Contraindication...
Contents: 1. Pharmacological action 2. Instructions for Cymbalta - indications for use 3. Contraindications and side effects of C...
Contents: 1. silhouette - pharmacological effect 2. silhouette - how to use 3. Contraindications pills silhouette 4. Side eff...